Crescent Pharmaceutical Group
Our Group
Crescent Pharmaceutical Group brings together pharmaceutical businesses operating across medicine development, manufacturing, regulatory management, commercial supply and distribution.
The Group combines established UK operations with global in-house development and manufacturing capabilities and a wider network of carefully selected pharmaceutical partners. Together, these capabilities support the development and dependable supply of medicines across the UK and international markets.
Our Group structure enables specialist businesses to retain their individual expertise while benefiting from shared investment, pharmaceutical knowledge and the wider capabilities of Crescent Pharmaceutical Group.
Group Holding Company
Crescent Pharmaceuticals brings together the businesses and investments that form Crescent Pharmaceutical Group, providing strategic oversight and supporting the long-term development of the Group's pharmaceutical operations.
Generic Medicines & Commercial Operations | UK
The Group's established UK generic medicines business, responsible for a substantial portfolio of pharmaceutical products and supplying medicines across retail pharmacy, wholesale, hospital and other healthcare channels.
Crescent Pharma sits at the centre of the Group's UK commercial operations, connecting product development, manufacturing, regulatory management and supply with the requirements of customers and healthcare providers.
UK Manufacturing
Pharmaceutical Manufacturing, Beta-lactam Antibiotics, Controlled Drugs & Specials | London
Crescent Manufacturing provides UK pharmaceutical manufacturing capability across a range of dosage forms and specialist production requirements. The operation forms an important part of the Group's strategy to strengthen UK manufacturing capacity while complementing Crescent's global manufacturing network and qualified contract manufacturing partners.
Pharmaceutical Manufacturing,
Controlled Drugs & Specials |
Westhoughton
Crescent Medical expands the Group's UK manufacturing capability across solid dosage forms, controlled drugs, unlicensed specials and oral liquids, supported by pharmaceutical production, packaging and associated operational infrastructure. The site increases the breadth and flexibility of Crescent's domestic manufacturing network and supports the Group's long-term investment in UK pharmaceutical production.
Pharmaceutical Manufacturing & Specials | Mablethorpe
Thorpe Laboratories provides specialist UK manufacturing capability across powders, liquid and semi-solid pharmaceutical products, together with unlicensed specials. Its capabilities complement the Group's wider manufacturing network and provide additional flexibility across specialist dosage forms and smaller-volume production requirements.
Global Development & Manufacturing
Pharmaceutical Development & Manufacturing
Crescent R&D provides in-house pharmaceutical development and manufacturing capability supporting the progression of products from development through technology transfer and commercial production. Its scientific and manufacturing infrastructure strengthens Crescent's ability to develop new products internally and supports the continued expansion of the Group's pharmaceutical portfolio.
Pharmaceutical Development & Manufacturing
Zhaveri Pharmakem adds specialist pharmaceutical development and manufacturing expertise to Crescent's international operations. Its capabilities support formulation and product development across multiple dosage forms, technology transfer and commercial manufacture, complementing the Group's other development facilities and manufacturing operations.
Crescent International
European Pharmaceutical Operations
Crescent International provides a European platform for the continued development of the Group's international pharmaceutical business. The operation supports Crescent's strategy of extending its portfolio into additional markets while developing the regulatory and commercial infrastructure required for sustainable European growth.
One Group, Wider Capability
The strength of Crescent Pharmaceutical Group lies not in any single business or facility, but in the way its capabilities work together.
Development
In-house pharmaceutical development supported by specialist development partners.
Manufacturing
UK and global manufacturing capability complemented by qualified CMOs and CDMOs.
Quality & Regulatory
Quality Assurance, Quality Control and Regulatory Affairs supporting products throughout their lifecycle.
Supply & Distribution
Strategic sourcing, stockholding and licensed pharmaceutical distribution supporting continuity of supply.
This structure gives Crescent greater control across the pharmaceutical lifecycle while retaining the flexibility to select the most appropriate development, manufacturing and supply route for individual products.
Investing in the Group for the Long Term
Crescent continues to invest in pharmaceutical businesses, facilities, development capability, manufacturing infrastructure, technology and people. Acquisition has formed an important part of the Group's development alongside organic investment and portfolio expansion. Each addition to the Group is intended to strengthen the wider pharmaceutical platform — adding capability, expertise, capacity or access to new markets.
Together, our businesses are building a broader pharmaceutical group with the capabilities required to develop, manufacture and supply medicines reliably for the long term.